HUTCHMED (China) (HMDCF) Preferred Shares (2019)
HUTCHMED (China)'s (HMDCF) quarterly Preferred Shares came in at $66.7 million in Q3 2019, little changed quarter-over-quarter from $66.7 million in Q2 2019.
Powered by 
Analysis
HUTCHMED (China) (HMDCF) Preferred Shares (2019) Analysis & Trends
HUTCHMED (China) (HMDCF) has reported Preferred Shares for 1 consecutive years, with $66.7 million the latest figure, recorded in Q3 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.13 Bn | 197.14 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 181.20 Bn | 178.03 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 132.23 Bn | 124.38 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.91 Bn | 74.92 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 61.59 Bn | 56.41 Bn | 1.37 Bn | - |
| 6 | Moderna | 55.02 Bn | 49.89 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.05 Bn | 30.74 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.30 Bn | 30.01 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.18 Bn | 30.18 Bn | 1.16 Mn | - |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - | - |